Why do doctors prescribe older medications instead of newer, more effective ones?

Insurance formularies rank drugs by cost, not efficacy. If a newer drug isn't on the formulary -- or requires prior authorization -- many providers default to the covered option to avoid delays and paperwork. This isn't negligence; it's a rational response to a broken incentive structure.

What is step therapy and why does it exist?

Step therapy (also called 'fail first') requires patients to try and fail on a cheaper drug before their insurance will cover the one their doctor actually prescribed. It exists to save insurers money. It can delay effective treatment by weeks or months.

Does telehealth solve these problems?

Telehealth removes some friction -- longer consultations, no waiting rooms, direct pharmacy fulfillment that bypasses formulary restrictions. It doesn't fix the entire healthcare system, but it gives patients more options when the traditional pathway isn't working.

Why Your Doctor Won't Prescribe What Actually Works

You've done the research. You know which medication has the strongest evidence for your condition. Your doctor agrees it's the right choice. And then your insurance says no.

This isn't a rare occurrence. It's the default experience for millions of Americans, and it shapes what gets prescribed far more than most patients realize.

The 15-Minute Problem

The average primary care visit in the United States lasts 15-18 minutes. In that window, a physician needs to review your history, address your concerns, perform any necessary examination, document everything for billing, and make treatment decisions.

Complex medication discussions -- comparing GLP-1 options for weight management, evaluating whether a compounded formulation is appropriate, discussing off-label uses backed by emerging evidence -- simply don't fit. The result: many patients receive whatever is fastest to prescribe and least likely to trigger an insurance fight.

This isn't a criticism of physicians. It's a criticism of a system that has turned medicine into a volume business.

How Insurance Decides What You Take

When your doctor writes a prescription, it enters a system designed primarily to minimize cost -- not to optimize your outcome.

Formularies are tiered lists maintained by insurers and pharmacy benefit managers (PBMs). Tier 1 drugs (generics) have the lowest copay. Tier 4-5 drugs (brand-name, specialty) can cost hundreds per month out of pocket. Your doctor may know that a Tier 4 drug is clearly better for you, but the system incentivizes prescribing from Tier 1.

Prior authorization requires your doctor's office to submit paperwork justifying why you need a specific drug. This process can take days to weeks. Many offices lack the staff to manage the volume of PA requests, so they prescribe the formulary alternative instead.

Step therapy is the most frustrating policy for patients. It requires you to try and fail on a cheaper drug before your insurance will cover the one your doctor recommended. If you need a GLP-1 medication for weight management, you may be required to first try and fail on an older, less effective option -- even when your doctor believes it's unlikely to work.

The Pharma Side of the Equation

Pharmaceutical pricing in the U.S. is a separate dysfunction. Brand-name GLP-1 medications can cost $1,000-1,500/month at list price. Manufacturers offer copay cards and patient assistance programs, but these create their own complexity and often exclude patients on government insurance.

Compounded medications exist partly because of this pricing gap. They offer an alternative pathway, but they are not FDA-approved and should not be assumed equivalent to branded products. The trade-off between cost accessibility and regulatory status is real, and patients deserve honest information about both sides.

What Telehealth Changes

Telehealth doesn't fix every systemic problem. But it removes some of the constraints that limit traditional prescribing:

Time: Online consultations aren't bound by the 15-minute visit window. Providers can spend more time evaluating your history and discussing options.

Formulary bypass: When you pay directly for your medication (rather than going through insurance), formulary restrictions don't apply. You and your provider can choose based on clinical evidence rather than what your PBM prefers.

Access: Patients in rural areas or underserved communities can access specialists and treatments that aren't available locally.

Transparency: On Varus, the price you see is the price you pay. There's no surprise billing, no copay confusion, and no prior authorization delay. You also won't be charged unless a licensed provider approves your treatment.

What Patients Can Do

Understanding the system is the first step to navigating it:

Ask your doctor what they'd prescribe if insurance wasn't a factor. The answer may be different from what they actually prescribe.
Request the clinical rationale for step therapy denials. Insurance companies must provide a reason, and appeals succeed more often than patients expect.
Explore direct-pay options when insurance adds more friction than value. For some treatments, the cash price through telehealth is lower than the insured copay.
Read the evidence yourself. You don't need a medical degree to understand the basics of a clinical trial. Resources like ClinicalTrials.gov and PubMed are publicly available.

The Bottom Line

The gap between what works and what gets prescribed is not a conspiracy -- it's a system of misaligned incentives operating at scale. Insurance companies optimize for cost. PBMs optimize for rebates. Pharmaceutical companies optimize for margin. And physicians are caught in the middle with 15 minutes and a stack of prior authorization forms.

Patients deserve to understand how this system works so they can make informed decisions about their own care. Sometimes the standard pathway is fine. Sometimes it's worth exploring alternatives.